Healthcare provider-mediated cascade testing of Lynch syndrome to at-risk family members: an interview study
Familial Cancer · 2025
DOI: 10.1007/s10689-025-00450-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Familial Cancer, 2025. Verfasst von Serene Ong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. s.ong@nus.edu.sg. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Genetic Testing, Family, Health Personnel. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Centre for Precision Health, Singapore, Institute for Health Innovation and Technology, National University of Singapore, Ministry of Education - Singapore.
Abstract (Originalsprache)
Cascade testing is often recommended for cancer predisposition syndromes, like Lynch syndrome (LS), to identify at-risk family members. The uptake of cascade testing is typically meditated by the proband's willingness to disclose their results with family members. Of which, cascade testing uptake rates in Singapore has been low, compared to global rates. Studies suggest that healthcare providers (HCPs)-meditated contact of at-risk family improves uptake, yet few have explored how receptive probands and family members are to such a model. Moreover, no studies to date have examined such a model of cascade testing in Asia. To address this gap, we interviewed 17 participants (probands and relatives) in Singapore to evaluate the acceptability and feasibility of HCP-mediated cascade testing for families with LS. Our findings show broad acceptability for HCP-mediated disclosure to relatives, driven by a sense of beneficence. However, HCP involvement introduced three unique issues to disclosure process: (i) their clinical position, which conveys expertise and authority; (ii) relational complexities within family dynamics; and (iii) the notion of family-centric privacy. We propose that HCP-mediated disclosure may be best implemented through a cooperative and flexible process, tailored to each family's unique circumstances. This approach balances the efficiency of providing accurate genetic information whilst sensitively navigating familial relationships, thereby improving uptake while respecting cultural and relational nuances.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. s.ong@nus.edu.sg.
- Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
- Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Sydney Health Ethics, University of Sydney, Sydney, Australia.
Förderung
- Centre for Precision Health, Singapore
- Institute for Health Innovation and Technology, National University of Singapore
- Ministry of Education - Singapore
Zitieren
APA
Ong, S., Chua, Z. Y., Yuen, J., Chiang, J., Zewen, Z., Ngeow, J., & Lysaght, T. (2025). Healthcare provider-mediated cascade testing of Lynch syndrome to at-risk family members: an interview study. Familial Cancer. https://doi.org/10.1007/s10689-025-00450-2
Vancouver
Ong S, Chua ZY, Yuen J, Chiang J, Zewen Z, Ngeow J, et al. Healthcare provider-mediated cascade testing of Lynch syndrome to at-risk family members: an interview study. Familial Cancer. 2025. doi:10.1007/s10689-025-00450-2
BibTeX
@article{Ong2025,
author = {Ong, Serene and Chua, Zi Yang and Yuen, Jeanette and Chiang, Jianbang and Zewen, Zhang and Ngeow, Joanne and Lysaght, Tamra},
title = {Healthcare provider-mediated cascade testing of Lynch syndrome to at-risk family members: an interview study},
journal = {Familial Cancer},
year = {2025},
doi = {10.1007/s10689-025-00450-2}
}
EUVIMED